After Replimune’s advanced melanoma drug was rejected for a second time, CEO Sushil Patel slammed the FDA for failing to ...
A new wave of device code phishing shows how threat actors are scaling account compromise using AI and end‑to‑end automation.
Lyell Immunopharma, Inc. (LYEL) 25th Annual Needham Virtual Healthcare Conference April 14, 2026 11:00 AM EDTCompany ParticipantsLynn Seely - ...
LB Pharmaceuticals Inc (LBRX) 25th Annual Needham Virtual Healthcare Conference April 16, 2026 11:45 AM EDTCompany ParticipantsHeather Turner - CEO ...
The risks and benefits of hormone replacement therapy use for menopausal symptoms in breast cancer survivors are examined in light of recent research.
There is a lack of studies on lifestyle interventions to improve asthma and allergic disease in women, and Sharmilee M.
In an interview with Targeted Oncology, Naomi Haas, MD, discusses the evolving landscape of adjuvant and neoadjuvant immune ...
The 2025 IDSA guidelines provide a comprehensive update on the management of cUTIs and reflect new evidence aiming to improve ...
A 2026 product overview examining Trimology's RS2 resistant starch formulation, probiotic ingredient research, BioSignal ...
New human research reveals how gut bacteria and creatine may restore brain energy and improve depression. If you have or know ...
A deep dive into how pharma funding shapes medical narratives, how the status quo perpetuates itself, and why science isn’t the meritocracy we imagine.
A 2026 informational overview of Metabo Drops coffee metabolism drop marketing claims, proprietary blend label disclosures, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results